» Articles » PMID: 30506679

Use of Platelet-rich Plasma to Suspend Noncultured Epidermal Cell Suspension Improves Repigmentation After Autologous Transplantation in Stable Vitiligo: a Double-blind Randomized Controlled Trial

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 2018 Dec 4
PMID 30506679
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Noncultured epidermal cell suspension (NCES) is an effective surgical modality for stable vitiligo which involves transplantation of the basal layer of epidermal cells onto the dermabraded vitiliginous patch. Platelet-rich plasma (PRP) has growth factors which may stimulate melanocyte migration and proliferation of keratinocytes and fibroblasts. The objective of this study was to compare the extent of repigmentation achieved by transplantation of NCES suspended in PRP with that of NCES suspended in phosphate buffered saline (PBS).

Methods: Twenty-one patients of stable vitiligo with at least two lesions of comparable size were included. The two vitiligo patches were randomized to receive NCES suspended in PRP or PBS. Postoperatively after 1 week, patients were given heliotherapy for 15 minutes daily.

Results: At 6 months follow-up, mean repigmentation by area method in PRP arm was 75.6 ± 30% SD and in non-PRP arm was 65 ± 34% SD (P = 0.0036). Patient satisfaction by visual analogue scale at 6 months also showed better results in PRP arm (P = 0.001). Assessment by three independent observers showed better repigmentation in PRP side both at 3 and 6 months.

Conclusions: Suspending NCES in PRP can result in significantly greater mean repigmentation and patient satisfaction than suspending in PBS.

Citing Articles

Stable vitiligo treated by transplantation of autologous melanocytes: a meta-analysis.

Cao X, Zhang W, Jia Z, Ma S, Liu L Arch Dermatol Res. 2025; 317(1):323.

PMID: 39891763 DOI: 10.1007/s00403-025-03846-3.


A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo.

Jafarzadeh A, Mohammad A, Goodarzi A J Cosmet Dermatol. 2024; 24(2):e16660.

PMID: 39509558 PMC: 11847760. DOI: 10.1111/jocd.16660.


The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology.

Rodriguez M, Mayrovitz H Cureus. 2024; 16(8):e68306.

PMID: 39350861 PMC: 11441414. DOI: 10.7759/cureus.68306.


Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials.

Jafarzadeh A, Mohammad A, Keramati H, Zeinali R, Khosravi M, Goodarzi A Stem Cell Res Ther. 2024; 15(1):176.

PMID: 38886861 PMC: 11184747. DOI: 10.1186/s13287-024-03800-6.


A Comparative Study to Evaluate the Efficacy of Fractional CO Laser + PRP Vs. Fractional CO Laser Alone in Patients with Vitiligo.

Ahlawat S, Kothiwala R, Meherda A J Cutan Aesthet Surg. 2024; 16(3):186-191.

PMID: 38189059 PMC: 10768947. DOI: 10.4103/JCAS.JCAS_103_22.